Complex regimen support
Chemotherapy, immunosuppressant, transplant, and HIV regimens with phased dosing, holds, ramps, and lab-driven adjustments.
What We Do: Healthcare Expertise
Medication Management Software Engineering
Medication errors can happen at every handoff, from prescribing to the bedside. We build clinical-grade medication management platforms with drug interaction alerts, e-prescribing, refill workflows, and adherence tracking that integrate cleanly with pharmacy systems and EHRs.
What is medication management software?
Medication management software tracks each medication from prescription to dispense, administration and adherence, with drug interaction alerts and reconciliation at every handoff. Agnotic Technologies builds it for digital health companies and hospitals, connected to pharmacy networks and EHRs through NCPDP SCRIPT, HL7 v2 and FHIR R4. The table shows what we build for each workflow.
| Workflow | Implementation focus | Clinical outcome |
|---|---|---|
| e-Prescribing (eRx) and EPCS | Surescripts-aligned eRx, controlled substance flows with two-factor identity proofing, and prescriber audit trails. | Faster prescribing with reduced transcription errors and DEA-aligned controlled substance handling. |
| Drug-drug and drug-allergy alerts | Real-time clinical decision support powered by First Databank, Medi-Span, or RxNorm-backed services with alert-fatigue tuning. | Fewer adverse drug events without overwhelming clinicians with noisy alerts. |
| Medication reconciliation | Bidirectional reconciliation across EHR, pharmacy, and patient-reported sources with conflict resolution UX. | Accurate active medication lists at transitions of care and discharge. |
| Barcode medication administration (BCMA) | Barcode and 2D scanning, five-rights enforcement, and tamper-evident administration logs at point of care. | Right patient, right drug, right dose, right route, right time - verified at the bedside. |
| Refill and pharmacy fulfillment | Refill request workflows, prior authorization handoffs, and pharmacy network integrations for retail and mail order. | Reduced refill abandonment and lower friction for chronic disease patients. |
| Patient adherence tracking | Smart reminders, dose tracking, MPR and PDC calculations, and adherence dashboards for care teams. | Earlier detection of non-adherence and targeted outreach for high-risk patients. |
What we build into medication platforms
Production capabilities we deliver inside medication management platforms.
Smart adherence reminders
Timezone-aware reminders, dose acknowledgement, missed-dose escalation, and caregiver notifications.
Lab and vitals integration
INR, eGFR, ANC, and weight-based dosing pipelines that integrate with EHR observations and patient-reported data.
Prior authorization workflows
ePA forms, payer integration, status polling, and clinician inboxes that close the loop on coverage decisions.
How do we tune drug interaction alerts?
Decision support patterns we use to reduce errors without burying clinicians in alerts.
- Severity-tuned alert thresholds aligned to formulary and patient context
- Override capture with structured reason codes for audit and analytics
- RxNorm, NDC, and SNOMED CT alignment for interoperable medication identity
- Continuous alert effectiveness monitoring and tuning
Which pharmacy and EHR standards do we connect to?
Integration patterns we apply to connect medication workflows with the rest of the care ecosystem.
- Surescripts, NCPDP SCRIPT, and HL7 v2 RXE/RXA messaging for pharmacy traffic
- FHIR R4 MedicationRequest, MedicationDispense, and MedicationStatement resources
- Bidirectional reconciliation with Epic, Oracle Health (Cerner) and athenahealth medication histories
- Replay-safe queues and idempotent writes for high-volume prescribing traffic
Common medication platform failures
Recurring weaknesses we find when reviewing medication products in production.
Unstructured medication identifiers
Impact: Free-text drug names break alerts, analytics, and pharmacy interfaces.
Mitigation: Anchor every medication to RxNorm or NDC with normalization at the entry boundary.
Alert fatigue from over-broad rules
Impact: Clinicians override real alerts because they appear too often.
Mitigation: Severity-tuned rules, context-aware suppression, and ongoing override analytics.
Adherence calculated without clinical context
Impact: False positives flag adherent patients and miss real non-adherence.
Mitigation: Regimen-aware MPR/PDC math, dose-hold handling, and PRN-aware adherence logic.
Facts and sources
Which rules and standards shape medication software?
Short facts we design prescribing, data protection and integration around, each linked to its primary source.
The HIPAA Security Rule requires administrative, physical and technical safeguards for electronic protected health information.
Source: 45 CFR Part 164 Subpart C (eCFR)A HIPAA covered entity may share protected health information with a business associate, such as a software vendor, only under a business associate agreement that commits the vendor to safeguard it.
Source: 45 CFR 164.502(e) and 164.504(e) (eCFR)To sign an electronic prescription for a controlled substance, the prescribing application must authenticate the practitioner with two of three factors: something they know, something they are and a separate device they have.
Source: 21 CFR 1311.115 (eCFR)In HL7 FHIR R4, the MedicationRequest resource is an order or request for both the supply of a medication and the instructions for administering it to a patient.
Source: HL7 FHIR R4, MedicationRequest
Frequently Asked Questions
Yes. We implement Surescripts-aligned eRx and EPCS workflows including identity proofing, two-factor signing, and DEA-aligned audit trails for controlled substances.
We integrate with First Databank, Medi-Span, Lexicomp, and open sources like RxNorm and openFDA, mapped through a normalization layer so the knowledge source can evolve without breaking the application.
Yes. We model phased protocols, weight and lab-driven dose calculations, holds, ramps, and pre-medications, with auditability for every change to the active regimen.
It depends on which workflows the first release covers, whether controlled substances and EPCS are in scope, which pharmacy networks, drug knowledge bases and EHRs it connects to, and how much medication history moves across. We give you a scoped plan after the scoping call.
Yes. Prescriptions and medication lists are protected health information, so Agnotic signs a business associate agreement before any PHI is shared with our team. HIPAA-ready medication management then means role-based access, audit logging and encryption of medication data, with PHI kept out of test environments.
Yes. A first release covers one workflow, such as medication review and reconciliation at discharge, with its alerts, audit trail and EHR connection working end to end. Prescribing, refills and adherence tracking follow in later releases.
AI tools help our engineers draft code and tests, but a person reviews every change, and it passes the same automated tests and security checks as any other code. Which tools may see your code or data is agreed with you at the start.
Need medication workflows engineered to clinical-grade reliability?
Get an implementation review across eRx, decision support, reconciliation, and adherence - with a concrete remediation plan.
contact@agnotic.com
Partnerships
contact@agnotic.com